Metastatic basaloid-squamous cell carcinoma of the esophagus treated by 5-fluorouracil and cisplatin

Yoshihiro Shibata, Eishi Baba, hiroshi ariyama, Ryusuke Miki, Nobumichi Ogami, Shuji Arita, Baoli Qin, Hitoshi Kusaba, Kenji Mitsugi, Hirokazu Noshiro, Takashi Yao, Shuji Nakano

研究成果: ジャーナルへの寄稿記事

15 引用 (Scopus)

抄録

Basaloid squamous cell carcinoma (BSC) of the esophagus is a rare malignant disease. We report here a patient with recurrent esophageal BSC, who was successfully treated by systemic chemotherapy containing 5-fluorouracil (5-FU) and cisplatin (CDDP). A 57-year-old woman was diagnosed as having squamous cell carcinoma of the esophagus upon endoscopic examination. Curative esophagectomy with lymph node dissection was performed under the thoracoscope. The pathological diagnosis of the surgical specimen was BSC. Five months after operation, the patient was diagnosed as having a recurrence of the BSC with metastases to the liver and spleen, and a right paraclavicular lymph node. She was given systemic chemotherapy consisting of continuous infusion of 800 mg/d of 5-FU and 3 h infusion of 20 mg/d of CDDP for 5 consecutive days every 4 wk. The metastatic lesions in the spleen and right paraclavicular lymph node disappeared, and the liver metastasis was apparently reduced in size after 2 courses of chemotherapy. The tumor regression was seen over 6 courses, with progression afterwards. Although subsequent treatment with CPT-11 and CDDP was not effective, docetaxel and vinorelbine temporarily controlled the tumor growth for 2 mo. 5-FU and CDDP combination may be useful for the patients with advanced BSC.

元の言語英語
ページ(範囲)3634-3637
ページ数4
ジャーナルWorld Journal of Gastroenterology
13
発行部数26
DOI
出版物ステータス出版済み - 7 14 2007

Fingerprint

Fluorouracil
Cisplatin
Esophagus
Squamous Cell Carcinoma
irinotecan
docetaxel
Drug Therapy
Thoracoscopes
Spleen
Lymph Nodes
Neoplasm Metastasis
Esophagectomy
Liver
Rare Diseases
Lymph Node Excision
Neoplasms
Recurrence
Growth
Therapeutics

All Science Journal Classification (ASJC) codes

  • Gastroenterology

これを引用

Metastatic basaloid-squamous cell carcinoma of the esophagus treated by 5-fluorouracil and cisplatin. / Shibata, Yoshihiro; Baba, Eishi; ariyama, hiroshi; Miki, Ryusuke; Ogami, Nobumichi; Arita, Shuji; Qin, Baoli; Kusaba, Hitoshi; Mitsugi, Kenji; Noshiro, Hirokazu; Yao, Takashi; Nakano, Shuji.

:: World Journal of Gastroenterology, 巻 13, 番号 26, 14.07.2007, p. 3634-3637.

研究成果: ジャーナルへの寄稿記事

Shibata, Y, Baba, E, ariyama, H, Miki, R, Ogami, N, Arita, S, Qin, B, Kusaba, H, Mitsugi, K, Noshiro, H, Yao, T & Nakano, S 2007, 'Metastatic basaloid-squamous cell carcinoma of the esophagus treated by 5-fluorouracil and cisplatin', World Journal of Gastroenterology, 巻. 13, 番号 26, pp. 3634-3637. https://doi.org/10.3748/wjg.v13.i26.3634
Shibata, Yoshihiro ; Baba, Eishi ; ariyama, hiroshi ; Miki, Ryusuke ; Ogami, Nobumichi ; Arita, Shuji ; Qin, Baoli ; Kusaba, Hitoshi ; Mitsugi, Kenji ; Noshiro, Hirokazu ; Yao, Takashi ; Nakano, Shuji. / Metastatic basaloid-squamous cell carcinoma of the esophagus treated by 5-fluorouracil and cisplatin. :: World Journal of Gastroenterology. 2007 ; 巻 13, 番号 26. pp. 3634-3637.
@article{d9f688c1184846ee937d797abf3ef40b,
title = "Metastatic basaloid-squamous cell carcinoma of the esophagus treated by 5-fluorouracil and cisplatin",
abstract = "Basaloid squamous cell carcinoma (BSC) of the esophagus is a rare malignant disease. We report here a patient with recurrent esophageal BSC, who was successfully treated by systemic chemotherapy containing 5-fluorouracil (5-FU) and cisplatin (CDDP). A 57-year-old woman was diagnosed as having squamous cell carcinoma of the esophagus upon endoscopic examination. Curative esophagectomy with lymph node dissection was performed under the thoracoscope. The pathological diagnosis of the surgical specimen was BSC. Five months after operation, the patient was diagnosed as having a recurrence of the BSC with metastases to the liver and spleen, and a right paraclavicular lymph node. She was given systemic chemotherapy consisting of continuous infusion of 800 mg/d of 5-FU and 3 h infusion of 20 mg/d of CDDP for 5 consecutive days every 4 wk. The metastatic lesions in the spleen and right paraclavicular lymph node disappeared, and the liver metastasis was apparently reduced in size after 2 courses of chemotherapy. The tumor regression was seen over 6 courses, with progression afterwards. Although subsequent treatment with CPT-11 and CDDP was not effective, docetaxel and vinorelbine temporarily controlled the tumor growth for 2 mo. 5-FU and CDDP combination may be useful for the patients with advanced BSC.",
author = "Yoshihiro Shibata and Eishi Baba and hiroshi ariyama and Ryusuke Miki and Nobumichi Ogami and Shuji Arita and Baoli Qin and Hitoshi Kusaba and Kenji Mitsugi and Hirokazu Noshiro and Takashi Yao and Shuji Nakano",
year = "2007",
month = "7",
day = "14",
doi = "10.3748/wjg.v13.i26.3634",
language = "English",
volume = "13",
pages = "3634--3637",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "26",

}

TY - JOUR

T1 - Metastatic basaloid-squamous cell carcinoma of the esophagus treated by 5-fluorouracil and cisplatin

AU - Shibata, Yoshihiro

AU - Baba, Eishi

AU - ariyama, hiroshi

AU - Miki, Ryusuke

AU - Ogami, Nobumichi

AU - Arita, Shuji

AU - Qin, Baoli

AU - Kusaba, Hitoshi

AU - Mitsugi, Kenji

AU - Noshiro, Hirokazu

AU - Yao, Takashi

AU - Nakano, Shuji

PY - 2007/7/14

Y1 - 2007/7/14

N2 - Basaloid squamous cell carcinoma (BSC) of the esophagus is a rare malignant disease. We report here a patient with recurrent esophageal BSC, who was successfully treated by systemic chemotherapy containing 5-fluorouracil (5-FU) and cisplatin (CDDP). A 57-year-old woman was diagnosed as having squamous cell carcinoma of the esophagus upon endoscopic examination. Curative esophagectomy with lymph node dissection was performed under the thoracoscope. The pathological diagnosis of the surgical specimen was BSC. Five months after operation, the patient was diagnosed as having a recurrence of the BSC with metastases to the liver and spleen, and a right paraclavicular lymph node. She was given systemic chemotherapy consisting of continuous infusion of 800 mg/d of 5-FU and 3 h infusion of 20 mg/d of CDDP for 5 consecutive days every 4 wk. The metastatic lesions in the spleen and right paraclavicular lymph node disappeared, and the liver metastasis was apparently reduced in size after 2 courses of chemotherapy. The tumor regression was seen over 6 courses, with progression afterwards. Although subsequent treatment with CPT-11 and CDDP was not effective, docetaxel and vinorelbine temporarily controlled the tumor growth for 2 mo. 5-FU and CDDP combination may be useful for the patients with advanced BSC.

AB - Basaloid squamous cell carcinoma (BSC) of the esophagus is a rare malignant disease. We report here a patient with recurrent esophageal BSC, who was successfully treated by systemic chemotherapy containing 5-fluorouracil (5-FU) and cisplatin (CDDP). A 57-year-old woman was diagnosed as having squamous cell carcinoma of the esophagus upon endoscopic examination. Curative esophagectomy with lymph node dissection was performed under the thoracoscope. The pathological diagnosis of the surgical specimen was BSC. Five months after operation, the patient was diagnosed as having a recurrence of the BSC with metastases to the liver and spleen, and a right paraclavicular lymph node. She was given systemic chemotherapy consisting of continuous infusion of 800 mg/d of 5-FU and 3 h infusion of 20 mg/d of CDDP for 5 consecutive days every 4 wk. The metastatic lesions in the spleen and right paraclavicular lymph node disappeared, and the liver metastasis was apparently reduced in size after 2 courses of chemotherapy. The tumor regression was seen over 6 courses, with progression afterwards. Although subsequent treatment with CPT-11 and CDDP was not effective, docetaxel and vinorelbine temporarily controlled the tumor growth for 2 mo. 5-FU and CDDP combination may be useful for the patients with advanced BSC.

UR - http://www.scopus.com/inward/record.url?scp=34547409850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547409850&partnerID=8YFLogxK

U2 - 10.3748/wjg.v13.i26.3634

DO - 10.3748/wjg.v13.i26.3634

M3 - Article

VL - 13

SP - 3634

EP - 3637

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 26

ER -